Asian Pacific Journal of Cancer Prevention

  • 제14권8호
  • /
  • Pages.4727-4731
  • /
  • 2013
  • /
  • 1513-7368(pISSN)
  • /
  • 2476-762X(eISSN)
아시아태평양암예방학회 (Asian Pacific Journal of Cancer Prevention)
권호 표지
DOI QR코드

DOI QR Code

Pyogenic Liver Abscess as a Warning Sign for Primary Liver Cancer: A Nationwide Population-based Study

  • Huang, Wen-Kuan (Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine) ;
  • Lin, Yung-Chang (Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine) ;
  • Chiou, Meng-Jiun (Department of Public Health, College of Medicine: Biostatistics Core Laboratory, Molecular Medicine Research Center, Chang Gung University) ;
  • Yang, Tsai-Sheng (Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine) ;
  • Chang, John Wen-Cheng (Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine) ;
  • Yu, Kuang-Hui (Division of Rheumatology, Allergy and Immunology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine) ;
  • Kuo, Chang-Fu (Division of Rheumatology, Allergy and Immunology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine) ;
  • See, Lai-Chu (Department of Public Health, College of Medicine: Biostatistics Core Laboratory, Molecular Medicine Research Center, Chang Gung University)
  • 발행 : 2013.08.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background: There have been no large-scale population-based studies to estimate the subsequent risk of primary liver cancer (PLC) among patients with pyogenic liver abscess (PLA). This study aimed to provide relevant data. Materials and Methods: The Taiwan Longitudinal Health Insurance Database for the years 2000 and 2005 was used. The PLA group were adult inpatients who were newly diagnosed with PLA from 2000 to 2008. The control group was randomly selected and matched with the PLA group in terms of age, sex, and date in which medical treatment was sought other than for PLA. Results: There were 1,987 patients each in the PLA and control groups. In total, 56 had PLC, 48 (2.4%, 601.5 per 100,000 person-years) from the PLA group, and 8 from the control group. After adjusting for potential covariates, the hazard ratio of PLC for the PLA group was 3.4 times that of the control group (95% confidence interval = 1.6-7.3, p <0.001). The PLC risk for the PLA group was significantly higher within the first year after PLA diagnosis (hazard ratio: 35.4) as compared with the control group and became insignificant (hazard ratio: 2.0, 95% confidence interval = 0.8-4.9) more than one year after PLA diagnosis. Conclusions: Patients with PLA have a higher rate of PLC than matched controls, especially within the first year after the diagnosis of PLA, suggesting PLA is a warning sign for PLC.

키워드

참고문헌

  1. Beasley RP, Hwang LY, Lin CC, Chien CS (1981). Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet, 2, 1129-33.
  2. Chong VH, Lim KS (2009). Pyogenic liver abscess as the first manifestation of hepatobiliary malignancy. Hepatobiliary Pancreat Dis Int, 8, 547-50.
  3. Copeland KT, Checkoway H, McMichael AJ, Holbrook RH (1977). Bias due to misclassification in the estimation of relative risk. Am J Epidemiol, 105, 488-95.
  4. Coussens LM, Werb Z (2002). Inflammation and cancer. Nature, 420, 860-7. https://doi.org/10.1038/nature01322
  5. El-Serag HB (2011). Hepatocellular carcinoma. N Engl J Med, 365, 1118-27. https://doi.org/10.1056/NEJMra1001683
  6. Grivennikov SI, Greten FR, Karin M (2010). Immunity, inflammation, and cancer. Cell, 140, 883-99. https://doi.org/10.1016/j.cell.2010.01.025
  7. Huang CI, Wang LY, Yeh ML, et al (2009). Hepatocellular carcinoma associated with liver abscess. Kaohsiung J Med Sci, 25, 537-43. https://doi.org/10.1016/S1607-551X(09)70546-7
  8. Jemal A, Bray F, Center MM et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
  9. Li C, Li G, Miao R, et al (2012). Primary liver cancer presenting as pyogenic liver abscess: characteristics, diagnosis, and management. J Surg Oncol, 105, 687-91. https://doi.org/10.1002/jso.22103
  10. Lin YT, Liu CJ, Chen TJ, et al (2011). Pyogenic liver abscess as the initial manifestation of underlying hepatocellular carcinoma. Am J Med, 124, 1158-64. https://doi.org/10.1016/j.amjmed.2011.08.012
  11. Lochhead P, El-Omar EM (2007). Helicobacter pylori infection and gastric cancer. Best Pract Res Clin Gastroenterol, 21, 281-97. https://doi.org/10.1016/j.bpg.2007.02.002
  12. Matsuzaki K, Murata M, Yoshida K, et al (2007). Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma. Hepatology, 46, 48-57. https://doi.org/10.1002/hep.21672
  13. McGlynn KA, London WT. (2011). The global epidemiology of hepatocellular carcinoma: present and future. Clin Liver Dis, 15, 223-43, vii-x. https://doi.org/10.1016/j.cld.2011.03.006
  14. Montomoli J, Erichsen R, Norgaard M et al (2011). Survival of patients with primary liver cancer in central and northern Denmark, 1998-2009. Clin Epidemiol, 3, 3-10.
  15. National Health Insurance Research Database: Data subsets. Available : http://nhird.nhri.org.tw/en. Accessed 5 December 2012.
  16. Okuda K, Kondo Y, Nakano M, et al (1991). Hepatocellular carcinoma presenting with pyrexia and leukocytosis: report of five cases. Hepatology, 13, 695-700. https://doi.org/10.1002/hep.1840130414
  17. Shimizu Y, Kaneko F, Motoori T, Yokomori H (2011) Undifferentiated hepatocellular carcinoma difficult to distinguish from liver abscess. Intern Med, 50, 519-20. https://doi.org/10.2169/internalmedicine.50.4737
  18. Su CH, Shyr YM, Lui WY, P Eng FK (1997). Hepatolithiasis associated with cholangiocarcinoma. Br J Surg, 84, 969-973. https://doi.org/10.1002/bjs.1800840717
  19. Taiwan Cancer Registry. Available :http://www.bhp.doh.gov.tw/BHPnet/Portal/StatisticsShow.aspx?No=200911300001. Accessed 20 December 2012.
  20. Tsai FC, Huang YT, Chang LY, Wang JT (2008). Pyogenic liver abscess as endemic disease, Taiwan. Emerg Infect Dis, 14, 1592-600. https://doi.org/10.3201/eid1410.071254
  21. Tsukuma H, Hiyama T, Tanaka S, et al (1993). Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med, 328, 1797-801. https://doi.org/10.1056/NEJM199306243282501
  22. Yeh TS, Jan YY, Jeng LB, et al (1998). Hepatocellular carcinoma presenting as pyogenic liver abscess: characteristics, diagnosis, and management. Clin Infect Dis, 26, 1224-6. https://doi.org/10.1086/520290

피인용 문헌

  1. Distribution of common pathogens in patients with pyogenic liver abscess in China: a meta-analysis vol.35, pp.10, 2016, https://doi.org/10.1007/s10096-016-2712-y
  2. Does pyogenic liver abscess increase the risk of delayed-onset primary liver cancer? vol.96, pp.34, 2017, https://doi.org/10.1097/MD.0000000000007785